Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ibrance
Research
NIH precision medicine initiative tests preclinical drug combos
ComboMATCH is doing a bit of pharmaceutical matchmaking to see if preclinical evidence for cancer drug combos holds up beyond the lab.
Helen Floersh
Jun 5, 2023 11:21am
3 months after uncloaking, Zentalis guns for an IPO
Mar 9, 2020 8:13am
Pfizer Oncology hires MD Anderson researcher
Sep 11, 2019 10:10am
Lilly gets positive abemaciclib phase 3 data, plots 2017 NDA
Mar 20, 2017 8:16am
Astex bags milestone after Novartis cancer drug approved
Mar 14, 2017 9:28am
‘Spiderweb’ of lung cancer proteins snares new drug targets
Feb 17, 2017 3:12pm
